Technical Analysis for GDR - Genedrive Plc

Grade Last Price % Change Price Change
F 3.11 -4.18% -0.14
GDR closed up 4.0 percent on Wednesday, March 27, 2024, on 79 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Mar 28
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Wide Bands Range Expansion -4.18%
Oversold Stochastic Weakness -4.18%
New 52 Week Closing Low Bearish -0.35%
New 52 Week Low Weakness -0.35%
Stochastic Reached Oversold Weakness -0.35%
Wide Bands Range Expansion -0.35%
Down 3 Days in a Row Weakness -0.35%
Oversold Stochastic Weakness -0.35%
Wide Bands Range Expansion -11.03%
20 DMA Resistance Bearish -16.96%

   Recent Intraday Alerts

Alert Time
10 DMA Resistance about 2 hours ago
Gap Down Closed about 3 hours ago
Reversed from Down about 3 hours ago
Up 10% about 3 hours ago
Rose Above Previous Day's High about 3 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genedrive Plc Description

Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Gas Biotechnology Life Sciences Disease Clinic Drugs Laser Oncology Testing Skin Drug Development Skin Care E Testing Health Sciences Molecular Omics Clinical Research Genomics Microscopy Molecular Diagnostics Pharmacology Medical Genetics Profiling Pharmacogenomics Pre Clinical Development

Is GDR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.9
52 Week Low 3.0889
Average Volume 1,728,489
200-Day Moving Average 9.44
50-Day Moving Average 5.05
20-Day Moving Average 4.18
10-Day Moving Average 3.60
Average True Range 0.64
RSI (14) 35.06
ADX 16.12
+DI 18.14
-DI 18.52
Chandelier Exit (Long, 3 ATRs) 4.21
Chandelier Exit (Short, 3 ATRs) 5.01
Upper Bollinger Bands 5.59
Lower Bollinger Band 2.77
Percent B (%b) 0.17
BandWidth 67.29
MACD Line -0.50
MACD Signal Line -0.47
MACD Histogram -0.0326
Fundamentals Value
Market Cap 4.37 Million
Num Shares 134 Million
EPS -0.06
Price-to-Earnings (P/E) Ratio -54.17
Price-to-Sales 131.30
Price-to-Book 3.29
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.81
Resistance 3 (R3) 3.83 3.66 3.72
Resistance 2 (R2) 3.66 3.52 3.65 3.68
Resistance 1 (R1) 3.46 3.43 3.56 3.44 3.65
Pivot Point 3.29 3.29 3.34 3.28 3.29
Support 1 (S1) 3.09 3.15 3.19 3.06 2.85
Support 2 (S2) 2.92 3.06 2.91 2.82
Support 3 (S3) 2.71 2.92 2.79
Support 4 (S4) 2.69